InvestorsHub Logo
Followers 45
Posts 4461
Boards Moderated 0
Alias Born 03/20/2015

Re: Ready4bluesky post# 56427

Wednesday, 03/09/2016 6:10:33 AM

Wednesday, March 09, 2016 6:10:33 AM

Post# of 704322

So basically you have no concept of share price as it relates to market cap?


No IMHO it is the other way around.
You are still thinking of NWBO as a typical new startup bio-tech with a single product in the pipe-line. When DCVAX gets approved it is a game changer. It is an industry disrupter especially with Direct coming next. You need to think of this like a replacement therapy for chemo. That is the way big pharma views it and it is why they are so frightened of it. What is the market cap for companies with a large pipeline of chemo product DVCAX replaces. Novartis is $193 Billion and the stock price is $72.21 with 2.3 billion shares outstanding. It is similar story for Merck with a cap of $147 B and stock price of $52.45 with 2.7 B shares and JNJ with a market cap of $294 B and a stock price of $106.28 with 2.7 B shares. Why would a patient take a chemo drug with severe toxic side effects if they could take DCVAX instead where they have a fever for a few days and it treats many cancers the have no other effective treatement? The market cap for NWBO yesterday was $154 million with the a share price of $1.56 at close. Conservatively, the upside potential is at least 100X short term and could be >1000X (especially when you compare the number of shares of NWBO to the others) once they become profitable. The biggest problem is that they need to continue to funnel profits into new manufacturing capability to handle the demand (but what a problem to have). We will see. Hopefully some time this year. Hope that helps.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News